Search Within

Gary Schwartz

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (20)
Groups
  1. Department of Pathology and Laboratory Medicine (43)
  2. Department of Medicine (37)
  3. Solid Tumor Oncology Division (35)
  4. GSK Faculty (34)
  5. Tow Center for Developmental Oncology (TCDO) (27)
  6. Surgery (20)

More Groups

People
  1. Cristina Antonescu (24)
  2. Richard Carvajal (14)
  3. Mark Dickson (12)
  4. Mary Keohan (12)
  5. Samuel Singer (12)
  6. William Tap (12)

More People

Years
  1. 2014 (3)
  2. 2013 (17)
  3. 2012 (8)
  4. 2011 (4)
  5. 2010 (3)
  6. 2009 (2)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Cancer Research (3)
  3. Annals of Oncology (2)
  4. Clinical Cancer Research (2)
  5. Annals of Surgical Oncology (1)
  6. Archives of Ophthalmology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (3)
  4. American Medical Association (2)
  5. Elsevier Science, Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (43)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma
    Journal Article

    Patel, M.; Winston, C. B.; Marr, B. P.; Carvajal, R. D.; Schwartz, G. K.; Wolchok, J.; Busam, K.; Abramson, D. H.
    Archives of Ophthalmology (2011)

    Fulltext@MSK | Save
  • KIT as a therapeutic target in metastatic melanoma
    Journal Article

    Carvajal, R. D.; Antonescu, C. R.; Wolchok, J. D.; Chapman, P. B.; Roman, R. A.; Teitcher, J.; Panageas, K. S.; Busam, K. J.; Chmielowski, B.; Lutzky, J.; more...
    JAMA - Journal of the American Medical Association (2011)

    Fulltext@MSK | Save
  • A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
    Meeting Abstract

    Shah, M. A.; Smyth, E. C.; Shibata, S.; Yong, W.; Tang, L. H.; Janjigian, Y. Y.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • IGF2 overexpression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting
    Journal Article

    Hajdu, M.; Singer, S.; Maki, R. G.; Schwartz, G. K.; Keohan, M. L.; Antonescu, C. R.
    Journal of Pathology (2010)

    Fulltext@MSK | Save
  • Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
    Journal Article

    Barretina, J.; Taylor, B. S.; Banerji, S.; Ramos, A. H.; Lagos-Quintana, M.; Decarolis, P. L.; Shah, K.; Socci, N. D.; Weir, B. A.; Ho, A.; more...
    Nature Genetics (2010)

    Fulltext@MSK | Save
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
    Journal Article

    Maki, R. G.; D'adamo, D. R.; Keohan, M. L.; Saulle, M.; Schuetze, S. M.; Undevia, S. D.; Livingston, M. B.; Cooney, M. M.; Hensley, M. L.; Mita, M. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma
    Journal Article

    Singer, S.; Socci, N. D.; Ambrosini, G.; Sambol, E.; Decarolis, P.; Wu, Y.; O'Connor, R.; Maki, R.; Viale, A.; Sander, C.; more...
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor
    Journal Article

    Guo, T.; Agaram, N. P.; Wong, G. C.; Hom, G.; D'adamo, D.; Maki, R. G.; Schwartz, G. K.; Veach, D.; Clarkson, B. D; Singer, S.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A non-randomized phase II study of sequential irinotecan (CPT) and flavopiridol (F) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Abou-Alfa, G. K.; Carvajal, R. D.; Chung, K. Y.; Ghossein, R. A.; Capanu, M.; Gonen, M.; Jacobs, G.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save